Improving workplace health & safety through collaboration

Articles Unexplained illness halts COVID-19 vaccine trial

Unexplained illness halts COVID-19 vaccine trial

Principal Author / Publisher:Marcus Dela Cruz

Last Edited: Sep 10, 2020 By: Marcus Dela Cruz

Article Rating:
Body

Clinical trials of one of the most advanced experimental COVID-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, were “paused” Tuesday after a volunteer developed an unexplained illness.


With billions of people around the world still suffering from the fallout of the pandemic and the global death toll nearing 900,000, a worldwide race for a vaccine is under way, with nine companies already in late-stage Phase 3 trials.

Worldwide infections to date now stand at more than 27 million, and more than 890,000 people have died from the disease.


Russia has already approved a vaccine, and research published in The Lancet medical journal last week said patients involved in early tests developed antibodies with “no serious adverse events.”

But scientists cautioned the trials were too small.


Keywords
Article Rating

This article has been read 301 times.

DISCLAIMER: All contents published on this website is for informational purposes only. In as much as we encourage write-ups to be originally written by the claimed authors, we might not be able to control those who will try to copy articles from other authors/writers. In view of the above, the owner and management of Safetyhow.com will not be liable for any loses, injuries, or damages from the display or use of the contents herein. Likewise, the owner and management will not be liable for any errors or omissions in the information stated. Furthermore, we highly recommend that any form of plagiarism or libel committed as a result or implication of the articles written by any specific author in this platform be reported to us immediately so that appropriate action will be given.

BROWSE ARTICLE BY CATEGORY

BROWSE ARTICLE BY INDUSTRY